Delivery Order SPE2DB22D9367-SPE2DB25FSZ27
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,315.80 by the Medical Supply Chain division of the Defense Logistics Agency on July 25, 2025. The delivery order, which is expected to be completed by August 14, 2025, covers the supply of Mitosol 0.2mg kits in quantities of three units. This award was issued without a set-aside designation, and the place of performance is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,526.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through November 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract with the DLA under the SPE2DB program to provide a broad range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $26,316.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of MITOSOL 0.2 MG KITS and has a ceiling value of $26,316.00 with a performance period ending on December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $10,526.40 for Mitosol 0.2 mg kits. This firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the vendor's Park Ridge facility. The award carries no set-aside designation and is funded through the Medical Supply Chain division of the Department of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,631.60 on July 22, 2025, for Mitosol 0.2 mg kits. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the broader...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $5,021.26 from the Defense Logistics Agency's Medical Supply Chain division on September 2, 2025. The delivery order, which carries no set-aside designation, is expected to be completed by September 8, 2025, and represents a continuation of the company's ongoing pharmaceutical distribution services to Department of Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,443.50 by the Defense Logistics Agency's Medical Supply Chain division on July 23, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, represents a specific pharmaceutical product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- The Defense Logistics Agency awarded a delivery order valued at $23,684.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mitosol 0.2 mg kits. The contract is firm fixed-price with an ultimate completion date of August 25, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's competitive position as a small business in federal procurement markets. Performance will be...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract, valued at $5,263.24, is for the supply of MITOSOL 0.2 MG KITS with an ultimate completion date of October 4, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This federal contract award, valued at $3,947.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of Mitosol 0.2mg kits to support the medical supply needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ27Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,263.24 by the Defense Logistics Agency on August 20, 2025, for the supply of Mitosol 0.2 mg kits. The delivery order carries an ultimate completion date of September 11, 2025, and no set-aside designation was used in the procurement. This award represents a continuation of the company's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for military healthcare systems. This delivery order was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the Defense Logistics Agency to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs of Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated consistent success in competing for federal pharmaceutical contracts, leveraging its woman-owned small business status to secure contracts covering an extensive portfolio of medications, biologics, and medical consumables spanning oncology treatments, vaccines, contraceptive devices, and specialty pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 8/20/25 |